Clay B. Siegall

2016

In 2016, Clay B. Siegall earned a total compensation of $9.6M as President and CEO at Seattle Genetics, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$985,000
Option Awards$4,015,160
Salary$852,354
Stock Awards$3,686,600
Other$20,283
Total$9,559,397

Siegall received $4M in option awards, accounting for 42% of the total pay in 2016.

Siegall also received $985K in non-equity incentive plan, $852.4K in salary, $3.7M in stock awards and $20.3K in other compensation.

Rankings

In 2016, Clay B. Siegall's compensation ranked 558th out of 14,075 executives tracked by ExecPay. In other words, Siegall earned more than 96.0% of executives.

ClassificationRankingPercentile
All
558
out of 14,075
96th
Division
Manufacturing
178
out of 5,489
97th
Major group
Chemicals And Allied Products
42
out of 1,895
98th
Industry group
Drugs
27
out of 1,538
98th
Industry
Biological Products, Except Diagnostic Substances
8
out of 279
97th
Source: SEC filing on April 5, 2017.

Siegall's colleagues

We found six more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2016.

2016

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2016

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2016

Vaughn Himes

Seattle Genetics

Chief Technical Officer

2016

Darren Cline

Seattle Genetics

Former Executive Vice President, Commercial

2016

Todd Simpson

Seattle Genetics

Chief Financial Officer

2016

Jean Liu

Seattle Genetics

General Counsel

News

You may also like